Related Experiment Videos
Studying genotype-phenotype relationships: cardiovascular disease as an example.
Stefan-Martin Herrmann1, Martin Paul
1Institute of Clinical Pharmacology and Toxicology, Department of Clinical Pharmacology, Benjamin Franklin Medical Center, Freie Universität Berlin, Hindenburgdamm 30, 12200 Berlin, Germany. herrmann@medizin.fu-berlin.de
Journal of Molecular Medicine (Berlin, Germany)
|May 22, 2002
Summary
Identifying specific genes and genetic variations is key to understanding cardiovascular disease (CVD) mechanisms. This knowledge aids in pinpointing high-risk individuals for tailored treatments and personalized medical management.
Area of Science:
- Genetics
- Cardiology
- Genomics
Background:
- Cardiovascular disease (CVD) arises from complex interactions between environmental and genetic factors.
- The
- candidate gene
- approach is used to identify genes contributing to CVD by analyzing their polymorphic spectrum.
Purpose of the Study:
- To identify genes and genetic variants involved in cardiovascular disease pathophysiology.
- To improve understanding of disease mechanisms and facilitate early identification of at-risk individuals.
- To enable individually adapted clinical management strategies for cardiovascular disease.
Main Methods:
- Utilizing available human genome sequence data to locate candidate genes within their chromosomal context.
- Employing advanced sequencing technologies for reliable data on nucleotide sequence diversity across populations.
- Assessing disease-related or intermediate phenotypes, particularly in clinical settings.
Main Results:
- Advances in sequencing technology provide robust data on genetic variations.
- Improved identification of candidate gene sequences and their chromosomal locations.
- Enhanced ability to assess the impact of genetic variations on cardiovascular disease.
Conclusions:
- Identifying specific genes and genetic variants in cardiovascular disease pathophysiology significantly advances our understanding.
- This knowledge aids in identifying high-risk individuals and subgroups.
- Facilitates the development of targeted therapeutic interventions and personalized clinical management for cardiovascular disease.